Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 174.1 USD 1.38%
Market Cap: 307.7B USD
Have any thoughts about
Abbvie Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

14.9
Current
11
Median
3.9
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
14.9
=
Enterprise Value
354.7B USD
/
EBITDA
23.8B USD
All Countries
Close
Market Cap EV/EBITDA
US
Abbvie Inc
NYSE:ABBV
303.5B USD 14.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -218 674.5
US
Amgen Inc
NASDAQ:AMGN
155.8B USD 17.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.1B USD 24
US
Gilead Sciences Inc
NASDAQ:GILD
111.8B USD 9.8
US
Epizyme Inc
F:EPE
94.1B EUR -516.7
AU
CSL Ltd
ASX:CSL
132.3B AUD 20.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82B USD 16.1
US
Seagen Inc
F:SGT
39.3B EUR -59
NL
argenx SE
XBRU:ARGX
33.8B EUR -102.6
KY
Beigene Ltd
SSE:688235
233.5B CNY -33
EBITDA Growth
US
Abbvie Inc
NYSE:ABBV
Average EV/EBITDA: 17
14.9
28%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Amgen Inc
NASDAQ:AMGN
17.2
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.2
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.6 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -33 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
13
2-Years Forward
EV/EBITDA
11.9
3-Years Forward
EV/EBITDA
11

See Also

Discover More